Back to Search
JOHN CAMORIANO, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1396723425Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
19049(AZ)
Research & Publications (15)
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
PMID 19250674·Leuk Res·2009
4-observational
Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.
PMID 18054795·Leuk Res·2008
8-other
Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
PMID 17577035·J Clin Oncol·2007
3-trial
Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.
PMID 17133423·Am J Hematol·2007
5-case
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
PMID 17123268·Cancer·2007
8-other
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia.
PMID 17581608·Leukemia·2007
3-trial
Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
PMID 19065716·J Gastrointest Cancer·2007
3-trial
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
PMID 16675707·Blood·2006
6-review
Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
PMID 16505423·J Clin Oncol·2006
3-trial
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
PMID 16502355·Invest New Drugs·2006
3-trial
FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.
PMID 16406016·Leuk Res·2006
8-other
The Office of Advanced Technology: providing focus on the piloting and implementation of new technology.
PMID 15537131·J Healthc Inf Manag·2004
8-other
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
PMID 11986248·Blood·2002
5-case
Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.
PMID 11025699·J Urol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13400 E SHEA BLVD
SCOTTSDALE, AZ 85259 - Phone
- (480) 301-8000
Quick Facts
- NPI
- 1396723425
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile